Skip to content

David P Meeker, President and CEO at Rhythm Pharmaceuticals, sold RYTM on Sep 14, 2026

Data as of Oct 16

▼ SELL$242K2,300 shares at $105.19David P Meeker President and CEORYTM Rhythm Pharmaceuticals, Inc.
Watch RYTM
Traded
Sep 14, 2026
Disclosed
Sep 14, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

David P Meeker, President and CEO at Rhythm Pharmaceuticals, sold RYTM on Sep 14, 2026TRADEDDISCLOSED
RYTMSimilar stocks (XLV — its sector index fund), rebased to RYTM's price on the disclosure day
RYTM since disclosure
−15.9%
after the sale
Similar stocks (XLV) since disclosure
+5.3%
XLV — its sector index fund

Change in closing price from Sep 14, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLDavid P Meeker President and CEORYTM Rhythm Pharmaceuticals, Inc.$900Kdisclosed Sep 14 · filed the same day
  2. ▼ SELLDavid P Meeker President and CEORYTM Rhythm Pharmaceuticals, Inc.$190Kdisclosed Sep 14 · filed the same day
  3. ▼ SELLDavid P Meeker President and CEORYTM Rhythm Pharmaceuticals, Inc.$655Kdisclosed Sep 14 · filed the same day
  4. ▼ SELLDavid P Meeker President and CEORYTM Rhythm Pharmaceuticals, Inc.$3.1Mdisclosed Sep 14 · filed the same day

See every trade on RYTM →